Most Read News

This approval is for the abbreviated new drug application (ANDA) of Bromfenac Ophthalmic Solution, 0.07%, which is used to treat postoperative inflammation and pain in patients undergoing cataract surgery.

CPPIB owned a 5.96% interest in Delhivery. On April 25, it reduced its shareholding in Delhivery by 2.77% through block trades.

The NSE indicated that the derivative contracts for these securities had surpassed 95% of the MWPL, leading to their inclusion in the ban period.

Listing Price: ₹356 on NSE (39.06% premium), ₹352 on BSE (37.52% premium)

Barclays joins UBS Group AG and Julius Baer Group Ltd. as companies expanding their wealth management operations in the area.

As part of this collaboration, Infosys will migrate Sector Alarm's disparate on-premises ERP platform to Microsoft Dynamics 365 Finance and Operations (F&O), enhancing their financial and operational models.

Mankind Pharma's stock increased by more than 4% after the block deal. Mankind Pharma's shares were trading at ₹2,169 on the NSE at 09.23 am.

iDATA's audited consolidated financials show revenues of ~ ₹246 Crore and EBITDA of ~ ₹144 Crore in CY2023.

The pressure from these major stocks pulled the benchmarks further down, reflecting investor concerns and market volatility.

India's vehicle retail sales increased by only 0.73% year on year in June, owing to delayed monsoons in several parts of the nation.